Dr. Ann T. Sutton, M.D.
Pathology (Anatomic Pathology & Clinical Pathology Physician)
- Medicare participating
At a glance
- Medical school
- Wake Forest University School of Medicine (1995)
- Years since graduation
- 31
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 274
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1995Medical school: Wake Forest University School of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Anatomic Pathology & Clinical Pathology Physician primary
NC license 9701611 -
Cytopathology Physician
NC license 9701611
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Ecu Health Medical Center Greenville, NC
Medical groups
- Vidant Medical Group LLC (1,012 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 274
- Services billed
- 1,028
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Special stained specimen slides to examine tissue, each additional procedure | 488 | 118 |
| Pathology examination of tissue using a microscope, intermediate complexity | 406 | 269 |
| Evaluation of fine needle aspirate with interpretation and report | 212 | 149 |
| Cell examination of specimen, selective cellular enhancement technique | 183 | 148 |
| Special stained specimen slides to examine tissue, initial procedure | 155 | 135 |
| Evaluation of fine needle aspirate | 146 | 101 |
| Special stained specimen slides to identify organisms including interpretation and report | 38 | 24 |
| Microscopic genetic analysis of tumor, manual | 36 | 25 |
| Examination of archival tissue for genetic analysis | 32 | 29 |
| Pathology examination of tissue using a microscope, moderately high complexity | 29 | 23 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 2 companies reported 2 payments worth $41.87 in total to this clinician.
| Roche Diagnostics Corporation | $26.49 |
|---|---|
| Merck Sharp & Dohme LLC | $15.38 |
| Food and Beverage | $41.87 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.